approved

Приложение 1 на ПЛС от 02.10.2019 г.

Unique identificator:  64f34e29-0ba5-4f00-82d0-0989aad92df5

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-10-03 09:08:40
  • Created by: georgi_sivchev
  • Updated at: 2019-10-03 09:08:40
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

R03AK08 Beclometasone dipropionate/ formoterol fumarate dihydrate R03AK08 Beclometasone dipropionate/ formoterol fumarate dihydrate
R03AK08 beclometasone, formoterol Foster Pressurised inhalation, solution 0,1 mg/0,006 mg - 120 doses 1 Chiesi Pharmaceuticals GmbH, Австрия 4 UD 65.78 - 2.15867 64.76 100% 64.76 J44.8,J45.0,J45.1 № 33/21.08.2009; КЦРР-2924/20.03.2013 г; НСР-2384/21.01.2014; НСР-3867/20.06.2014; НСР-4746/02.10.2014; НСР-12738/19.05.2017; НСР-16269/27.07.2018 02.09.2019 08.09.2012 Активен 3218
R03AK08 beclometasone, formoterol Foster NEXThaler Inhalation powder 100 mcg/6 mcg/dose - 120 doses 1 Chiesi Pharmaceuticals GmbH, Австрия 4 UD 64.76 - 2.15867 64.76 100% 64.76 не се прилага на лица под 18 години J44.8,J45.0,J45.1 НСР-4734/02.10.2014.; НСР-6412/12.06.2015; НСР-8223/22.02.2016; НСР-10676/21.10.2016 и НСР-11029/25.11.2016 (предварително изпълнение); НСР-13278/20.07.2017; НСР-15354/30.03.2018; НСР-17355/30.11.2018; НСР-19456/07.08.2019 02.09.2019 Активен 3217
R03AK10 Fluticasone furoate/Vilanterol R03AK10 Fluticasone furoate/Vilanterol
R03AK10 Fluticasone furoate, Vilanterol Relvar Ellipta Inhalation powder, pre dispensed 184 mcg/22 mcg UD 30 doses GlaxoSmithKline (Ireland) Limited, Ирландия 1 UD 71.76 - 2.392 71.76 100% 71.76 J45.0, J45.1- Не се прилага при лица, ненавършили 12 години J45.0,J45.1 НСР-4582/15.09.2014.; НСР-4697/26.09.2014.; НСР-6381/03.06.2015.; НСР-18241/22.03.2019; НСР-19272/18.07.2019 02.09.2019 Активен 3176
R03AK10 Fluticasone furoate, Vilanterol Relvar Ellipta Inhalation powder, pre dispensed 92 mcg/22 mcg UD 30 doses GlaxoSmithKline (Ireland) Limited, Ирландия 1 UD 61.37 - 2.04567 61.37 100% 61.37 J45.0, J45.1- Не се прилага при лица, ненавършили 12 години J44.8,J45.0,J45.1 НСР-4581/15.09.2014; НСР-6382/03.06.2015. и КП-360/26.08.2015.; НСР-9363/19.05.2016; НСР-13589/25.08.2017; НСР-15732/25.05.2018; НСР-18154/07.03.2019; НСР-19271/18.07.2019 02.09.2019 Активен 3177
R03AK11 Fluticasone propionate/formoterol fumarate dihydrate R03AK11 Fluticasone propionate/formoterol fumarate dihydrate
R03AK11 Fluticasone, Formoterol Flutiform Pressurised inhalation, suspension 250 mcg/10 mcg (120 впръсквания) 1 Mundipharma GmbH, Австрия 2 UD 108.28 - 1.80467 108.28 100% 108.28 Само при възрастни J45.0,J45.1 НСР-3169/07.04.2014.; НСР-5291/ 18.12.2014.; НСР-7183/09.10.2015.; КП-31/26.04.2018 и НСР-15070/23.02.2018; НСР-19671/29.08.2019 02.10.2019 Активен 3457
R03AK11 Fluticasone, Formoterol Flutiform Pressurised inhalation, suspension 125 mcg/5 mcg (120 впръсквания) 1 Mundipharma GmbH, Австрия 4 UD 66.8 - 2.22667 66.8 100% 66.8 При възрастни и деца над 12 години J45.0,J45.1 НСР-3169/07.04.2014.; НСР-5290/ 18.12.2014.; НСР-7184/09.10.2015.; КП-30/26.04.2018 и НСР-15071/23.02.2018; КП-41/25.04.2019 и НСР-17892/07.02.2019 02.06.2019 Активен 3456
R03AK11 Fluticasone, Formoterol Flutiform K-haler Pressurised inhalation, suspension 125 mcg/5 mcg per actuation (120 впръсквания) 1 Mundipharma GmbH, Австрия 4 UD 68.57 - 2.22667 66.8 100% 66.8 При възрастни и деца над 12 години J45.0,J45.1 НСР-15803/08.06.2018 02.06.2019 Активен 16144
R03AL03 Umeclidinium bromide/ Vilanterol R03AL03 Umeclidinium bromide/ Vilanterol
R03AL03 Umeclidinium Bromide, Vilanterol ANORO ELLIPTA Inhalation powder, pre dispensed 55 mcg/22 mcg 1 inhaler (30 doses) GlaxoSmithKline (Ireland) Limited, Ирландия 1 UD - 102.6 3.42 102.6 75% 76.95 J44.8 НСР-7453/10.11.2015.; НСР-9960/29.07.2016; НСР-12818/26.05.2017 г.; НСР-16690/30.08.2018; НСР-18473/22.04.2019 02.06.2019 Активен 4097
R03AL04 Indacaterol / Glycopyrronium bromide R03AL04 Indacaterol / Glycopyrronium bromide
R03AL04 Indacaterol and glycopyrronium bromide Ultibro Breezhaler Inhalation powder, hard capsule 85 mcg /43 mcg 30 x 1 capsules (unit dose) + 1 inhaler Novartis Europharm Limited, Ирландия 1 UD (= 1 dose inhalation powder) - 102.24 3.06324 91.9 75% 68.92 J44.8 НСР-4636/15.09.2014; НСР-6138/29.04.2015.; НСР-11345/30.12.2016; Протокол 244/28.09.2017; НСР-14186/13.10.2017; НСР-15740/25.05.2018; НСР-16615/24.08.2018; НСР-17887/07.02.2019 02.04.2019 Активен 3857
R03AL05 Aclidinum bromide, Formoterol R03AL05 Aclidinum bromide, Formoterol
R03AL05 Aclidinum bromide, Formoterol Brimica Genuair Inhalation powder 340 mcg/12 mcg mcg 1 inhaler with 60 actuations AstraZeneca AB, Швеция 2 UD - 102.95 3.43167 102.95 75% 77.21 J44.8 НСР-14441/17.11.2017 02.01.2018 Активен 15934
R03AL05 Aclidinum bromide, Formoterol Duaklir Genuair Inhalation powder 340 mcg/12 mcg mcg 1 inhaler with 60 actuations AstraZeneca AB, Швеция 2 UD - 102.97 3.43167 102.95 75% 77.21 J44.8 НСР-11253/16.12.2016 (допуска се предварително изпълнение); НСР-13783/12.09.2017 02.01.2018 Активен 15519
R03AL06 Tiotropium bromide, Olodaterol R03AL06 Tiotropium bromide, Olodaterol
R03AL06 Tiotropium bromide, Olodaterol Spiolto Respimat Inhalation solution 2,5 mcg/2,5 mcg Single pack: 1 cartridge, providing 60 puffs (30 medicinal doses) Boehringer Ingelheim International GmbH, Германия 2 UD - 92.76 3.092 92.76 75% 69.57 J44.8 НСР-19823/20.09.2019 - Предварително изпълнение 02.10.2019 Активен 16702
R03AL06 Tiotropium bromide, Olodaterol Spiolto Respimat Inhalation solution 2,5 mcg/2,5 mcg 1 Respimat reusable inhaler and 1 cartridge, providing 60 puffs (30 medicinal doses) Boehringer Ingelheim International GmbH, Германия 2 UD - 92.99 3.092 92.76 75% 69.57 J44.8 НСР-11252/16.12.2016 г. (предварително изпълнение); НСР-13795/12.09.2017; НСР-15684/17.05.2018; НСР-17850/31.01.2019 предварително изпъленение; НСР-19597/21.08.2019; НСР-19215/12.07.2019 02.10.2019 Активен 15523
R03AL08 Fluticasone furoate, umeclidinium, vilanterol R03AL08 Fluticasone furoate, umeclidinium, vilanterol
R03AL08 Fluticasone furoate, umeclidinium, vilanterol Trelegy Ellipta Inhalation powder, pre dispensed 92 mcg/55 mcg/22 mcg 1 inhaler (30 doses) GlaxoSmithKline Trading Services Limited, Ирландия 1 UD - 137.72 4.13 123.9 75% 92.93 J44.8 НСР-18448/11.04.2019 02.05.2019 Активен 16495
R03BA01 Beclometasone R03BA01 Beclometasone
R03BA01 Beclometasone Ecobec 100 MCG Easi-Breathe Pressurised inhalation, solution 100 mcg/dose - 200 doses mcg 1 Teva Czech Industries s.r.o., Чешка република 1.5 mg 26.57 - 1.11911 14.92 100% 14.92 J45.0,J45.1 №38/27.08.2009; НСР-1804/25.11.2013; НСР-4307/05.08.2014; НСР-5554/29.01.2015. 16.02.2015 08.09.2012 Заличен 3123
R03BA01 Beclometasone Ecobec 250 MCG Easi-Breathe Pressurised inhalation, solution 250 mcg/dose - 200 doses mcg 1 Teva Czech Industries s.r.o., Чешка република 1.5 mg 37.3 - 1.11911 37.3 100% 37.3 J45.0,J45.1 №35/21.08.2009; НСР-5072/21.11.2014; НСР-7130/24.09.2015 16.10.2015 08.09.2012 Заличен 3354
Showing 4151 to 4176 of 4380 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте